1. Home
  2. NNBR vs PLX Comparison

NNBR vs PLX Comparison

Compare NNBR & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NN Inc.

NNBR

NN Inc.

HOLD

Current Price

$3.50

Market Cap

162.5M

Sector

Industrials

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.36

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNBR
PLX
Founded
1980
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.5M
168.4M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NNBR
PLX
Price
$3.50
$2.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$12.00
AVG Volume (30 Days)
4.9M
677.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
3.60
N/A
EPS
N/A
0.22
Revenue
$770,657,000.00
$52,744,000.00
Revenue This Year
$8.60
$36.81
Revenue Next Year
$6.30
N/A
P/E Ratio
N/A
$10.95
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$1.41
52 Week High
$4.44
$3.19

Technical Indicators

Market Signals
Indicator
NNBR
PLX
Relative Strength Index (RSI) 54.40 57.49
Support Level $1.31 $2.06
Resistance Level $4.44 $2.44
Average True Range (ATR) 0.36 0.09
MACD -0.04 -0.01
Stochastic Oscillator 31.46 50.00

Price Performance

Historical Comparison
NNBR
PLX

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: